Perrigo Ordinary Shares reported $2.72B in Current Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Bayer BAYN:GR EUR 37.76B 652M
Catalent CTLT:US USD 2.92B 220M
Coherus Biosciences CHRS:US USD 381.23M 67.04M
Corcept Therapeutics CORT:US USD 499.25M 46.85M
Endo International Ordinary Shares ENDP:US USD 2.05B 145.74M
Horizon Pharma HZNP:US USD 3.65B 240.83M
Lannett LCI:US USD 250.53M 14.13M
Nestle NESN:VX 35.06B 577M
Pacira Pharmaceuticals PCRX:US USD 498.33M 35.08M
Perrigo Ordinary Shares PRGO:US USD 2.72B 136.6M
Phibro Animal Health PAHC:US USD 581.69M 11.61M
Prestige Brands PBH:US USD 408.85M 72.19M
Reckitt Benckiser Group PLC RB/:LN GBP 5.28B 266M
Supernus Pharmaceuticals SUPN:US USD 734.15M 70.26M
Teva Pharmaceutical TEVA:IT USD 12.05B 598M
Xeris Pharmaceuticals Inc XERS:US USD 186.82M 37.9M
Zoetis ZTS:US USD 7.51B 955M